San Francisco, CA, United States of America

Laurent P Debien

USPTO Granted Patents = 4 

Average Co-Inventor Count = 16.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovator's Path: Laurent P Debien's Journey in Inventing Inhibitors of Peptidylarginine Deiminases

Introduction: Laurent P Debien is a dedicated inventor based in San Francisco, CA, who has made significant contributions to the field of therapeutic treatment targeting peptidylarginine deiminases (PADs). With a keen focus on developing novel compounds to combat diseases associated with PADs, Laurent has established himself as a prominent figure in the pharmaceutical innovation landscape.

Latest Patents: Laurent P Debien's latest patents revolve around the development of inhibitors of peptidylarginine deiminases, specifically targeting PAD4. These compounds have shown promise in the therapeutic treatment of diseases linked to PADs. The patents also encompass processes for synthesizing these compounds, methods for their application, and formulations for pharmaceutical compositions containing these groundbreaking compounds.

Career Highlights: Laurent P Debien is currently affiliated with Gilead Sciences, Inc., a leading biopharmaceutical company renowned for its innovative research in the healthcare industry. His tenure at Gilead Sciences has been marked by a relentless pursuit of groundbreaking discoveries and a commitment to advancing the field of medicine through cutting-edge inventions.

Collaborations: Throughout his career, Laurent has collaborated closely with esteemed colleagues like Eda Y Canales and Hyung-Jung Pyun. Together, they have fostered a dynamic environment of innovation and collaboration, driving forward the development of revolutionary treatments targeting PADs and related diseases.

Conclusion: Laurent P Debien's pioneering work in inventing inhibitors of peptidylarginine deiminases stands as a testament to his unwavering dedication to advancing healthcare through innovation. With a proven track record of patenting novel compounds and a collaborative spirit that fuels transformative discoveries, Laurent continues to shape the landscape of therapeutic treatments for diseases associated with PADs, leaving an indelible mark on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…